Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E
Cancer Cell Int. 2024; 24(1):415.
PMID: 39702144
PMC: 11660992.
DOI: 10.1186/s12935-024-03612-x.
Krishna B, Garg P, Ramisetty S, Subbalakshmi A, Kulkarni P, Salgia R
Sci Rep. 2024; 14(1):22670.
PMID: 39349529
PMC: 11442654.
DOI: 10.1038/s41598-024-72586-7.
Lu J, Liu X, Cen A, Hong Y, Wang Y
J Endocrinol Invest. 2024; 47(11):2873-2884.
PMID: 38748197
DOI: 10.1007/s40618-024-02388-1.
Karajovic J, Kovacevic B, Uzelac B, Stefik D, Jovanovic B, Ristic P
Cancers (Basel). 2024; 16(3).
PMID: 38339237
PMC: 10854783.
DOI: 10.3390/cancers16030485.
Saikia S, Postwala H, Athilingam V, Anandan A, Padma V, Kalita P
Curr Pharm Biotechnol. 2024; 25(15):1915-1938.
PMID: 38310451
DOI: 10.2174/0113892010265004231116092802.
Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia.
Xie K, Chen S, Wang Y, Zeng M, Liu X, Liang Y
Transl Cancer Res. 2024; 12(12):3693-3702.
PMID: 38192996
PMC: 10774049.
DOI: 10.21037/tcr-23-429.
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update.
Tiuca R, Tiuca O, Pascanu I
Biomedicines. 2023; 11(4).
PMID: 37189693
PMC: 10135953.
DOI: 10.3390/biomedicines11041075.
Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.
Fang X, Chen X, Gao J, Tong L
Front Genet. 2023; 14:1157438.
PMID: 37153003
PMC: 10158935.
DOI: 10.3389/fgene.2023.1157438.
Association Between HOTAIR rs920778 and H19 rs3741219 Polymorphisms with Hashimoto's Thyroiditis (HT) and Graves' Disease (GD).
Beiramzadeh A, Heidari Z, Norouzi M, Saravani M
Rep Biochem Mol Biol. 2023; 11(3):377-385.
PMID: 36718300
PMC: 9883025.
DOI: 10.52547/rbmb.11.3.377.
Comparative G-Protein-Coupled Estrogen Receptor (GPER) Systems in Diabetic and Cancer Conditions: A Review.
Muhammad A, Forcados G, Yusuf A, Abubakar M, Sadiq I, Elhussin I
Molecules. 2022; 27(24).
PMID: 36558071
PMC: 9786783.
DOI: 10.3390/molecules27248943.
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1.
Kuo F, Wang Y, Liu C, Li Y, Lu C, Su S
Cancer Cell Int. 2022; 22(1):396.
PMID: 36494673
PMC: 9733112.
DOI: 10.1186/s12935-022-02817-2.
Association of Polymorphisms in the Long Non-Coding RNA with Recurrent Pregnancy Loss in a Korean Population.
Park H, Kim Y, Lee J, Ko E, Kwon M, Kim J
Genes (Basel). 2022; 13(11).
PMID: 36421813
PMC: 9690393.
DOI: 10.3390/genes13112138.
Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers.
Ghafouri-Fard S, Noie Alamdari A, Noee Alamdari Y, Abak A, Hussen B, Taheri M
Cancer Cell Int. 2022; 22(1):254.
PMID: 35964082
PMC: 9375325.
DOI: 10.1186/s12935-022-02676-x.
Association between long non-coding RNA HOTAIR polymorphism and lung cancer risk: A systematic review and meta-analysis.
Ke C, Feng X, Li J, Chen S, Hu X
Exp Ther Med. 2022; 24(2):540.
PMID: 35837044
PMC: 9257968.
DOI: 10.3892/etm.2022.11477.
Polymorphisms in lncRNA CCAT1 on the susceptibility of lung cancer in a Chinese northeast population: A case-control study.
Ji Y, Yang Y, Yin Z
Cancer Med. 2022; 12(1):500-512.
PMID: 35650713
PMC: 9844612.
DOI: 10.1002/cam4.4902.
LINC01087 Promotes the Proliferation, Migration, and Invasion of Thyroid Cancer Cells by Upregulating PPM1E.
Yin Y, Huang J, Shi H, Huang Y, Huang Z, Song M
J Oncol. 2022; 2022:7787378.
PMID: 35368894
PMC: 8975626.
DOI: 10.1155/2022/7787378.
Comprehensive Analysis of the PROSER2-AS1-Related ceRNA Network and Immune Cell Infiltration in Papillary Thyroid Carcinoma.
Wang T, Yu Q, Zhang W, Gao L
Int J Gen Med. 2022; 15:1647-1663.
PMID: 35210835
PMC: 8858959.
DOI: 10.2147/IJGM.S338019.
The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance.
Zhu J, Liu C, Wang D, Cao X, Wang S, Liu Y
Front Oncol. 2021; 11:706011.
PMID: 34447696
PMC: 8383148.
DOI: 10.3389/fonc.2021.706011.
Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma.
Li L, Wang J, Li Z, Qiu S, Cao J, Zhao Y
Cancer Manag Res. 2021; 13:6517-6525.
PMID: 34447269
PMC: 8382966.
DOI: 10.2147/CMAR.S312784.
Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinoma.
Du J, Li G, Li Y, Qiu X
Sci Rep. 2021; 11(1):16239.
PMID: 34376710
PMC: 8355328.
DOI: 10.1038/s41598-021-90538-3.